Bolt Biotherapeutics, Inc.
BOLT
Price:
$0.75
Market Cap:
$28.60M
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody program developed to repolarize critical cells in the tumor microenvironment by targeting cell-surface receptors on macrophages. It is also develo...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
BOLT
The PE Ratio as of July 2024 (TTM) for Bolt Biotherapeutics, Inc. (BOLT) is -0.45
According to Bolt Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.45. This represents a change of -43.55% compared to the average of -0.80 of the last 4 quarters.
Bolt Biotherapeutics, Inc. (BOLT) Historical PE Ratio (quarterly & annually)
How has BOLT PE Ratio performed in the past?
The mean historical PE Ratio of Bolt Biotherapeutics, Inc. over the last ten years is -13.80. The current -0.45 PE Ratio has changed 226.12% with respect to the historical average. Over the past ten years (40 quarters), BOLT's PE Ratio was at its highest in in the September 2001 quarter at 0. The PE Ratio was at its lowest in in the March 2020 quarter at -13.03.
Average
-13.80
Median
-8.94
Minimum
-37.61
Maximum
-0.57
Bolt Biotherapeutics, Inc. (BOLT) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Bolt Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 43.92%
Maximum Annual PE Ratio = -0.57
Minimum Annual Increase = -89.11%
Minimum Annual PE Ratio = -37.61
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -0.61 | 8.22% |
| 2022 | -0.57 | -67.78% |
| 2021 | -1.76 | -89.11% |
| 2020 | -16.12 | -57.12% |
| 2019 | -37.61 | 43.92% |
Bolt Biotherapeutics, Inc. (BOLT) Average PE Ratio
How has BOLT PE Ratio performed in the past?
The current PE Ratio of Bolt Biotherapeutics, Inc. (BOLT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.98
5-year avg
-11.33
10-year avg
-13.80
Bolt Biotherapeutics, Inc. (BOLT) PE Ratio vs. Peers
How is BOLT’s PE Ratio compared to its peers?
Bolt Biotherapeutics, Inc.’s PE Ratio is greater than Assembly Biosciences, Inc. (-1.60), greater than Neoleukin Therapeutics, Inc. (-0.98), greater than Instil Bio, Inc. (-0.66), less than CytomX Therapeutics, Inc. (7.44), greater than Achilles Therapeutics plc (-0.52), less than Spero Therapeutics, Inc. (3.28), greater than Nuvation Bio Inc. (-11.90), greater than NextCure, Inc. (-0.72),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.60 | $92.12M | |
| -0.98 | $8.20M | |
| -0.66 | $81.49M | |
| 7.44 | $116.88M | |
| -0.52 | $32.96M | |
| 3.28 | $77.47M | |
| -11.90 | $926.28M | |
| -0.72 | $45.88M |
Build a custom stock screener for Bolt Biotherapeutics, Inc. (BOLT) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bolt Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Bolt Biotherapeutics, Inc. (BOLT) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Bolt Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Bolt Biotherapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Bolt Biotherapeutics, Inc. (BOLT)?
What is the highest PE Ratio for Bolt Biotherapeutics, Inc. (BOLT)?
What is the 3-year average PE Ratio for Bolt Biotherapeutics, Inc. (BOLT)?
What is the 5-year average PE Ratio for Bolt Biotherapeutics, Inc. (BOLT)?
How does the current PE Ratio for Bolt Biotherapeutics, Inc. (BOLT) compare to its historical average?